AHR and melanoma: We recently reported that the Aryl hydrocarbon Receptor (AhR), a ligand‐dependent transcription factor is an upstream central node regulating the expression of BRAFi‐resistance genes and melanoma dedifferentiation (Corre et al,2018; Leclerc et al,2021; Paris et al, 2021).